This is a temporary backup site for TRENDS MENA while our primary website is being restored following a regional disruption affecting Amazon Web Services cloud infrastructure in the GCC.

Search Site

ADNOC Distribution 2025 dividend $700m

The company had reported EBITDA of $1.17 bn in 2025.

Empower okays $119.1m H2 2025 dividend

The dividend is equivalent to 43.75% of paid-up capital.

Alujain widens 2025 loss

The increase in loss is due to impairment charges, weaker prices.

Masar 2025 net profit $262m

Higher land plot sales boost revenue and operating income.

Tasnee’s 2025 losses deepen

The petrochemicals' company's revenue also fell 17.7 percent.

Global conference on Pharmaceutical Technologies concludes in Dubai

  • The largest-ever edition of DUPHAT, the 2023 event brought together more than 1,100 exhibiting companies.
  • The event also discussed on how countries in the region can collaborate to enhance partnerships in the pharmaceutical industry.

DUBAI, UAE – The 28th edition of the Dubai International Pharmaceutical Technologies Conference and Exhibition (DUPHAT) 2023 concluded.

 The three-day event, which concluded Thursday, took place at the Dubai World Trade Center and drew more than 26,000 visitors and participants from 82 countries.

Dr. Ali Al Sayed Hussain, Director of the Pharmaceutical Services Department at the Dubai Health Authority and Chairman of DUPHAT, said that the conference brought together experts from the pharmaceutical industry globally to discuss the challenges, solutions and the future of the industry.

He said the conference also focused on how countries in the region can collaborate to enhance partnerships in the pharmaceutical industry.

The largest-ever edition of DUPHAT, the 2023 event brought together more than 1,100 exhibiting companies.

The event featured 112 conference lectures and 15 workshops delivered by 140 experts and specialists.

DUPHAT attracted large participation from the student community and universities. A total of 330 posters displayed the latest breakthrough pharmaceutical and medical research at the event.